| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Heme oxygenase 2 |
|---|
| Ligand | BDBM50044424 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_976174 (CHEMBL2415823) |
|---|
| IC50 | 24500±n/a nM |
|---|
| Citation |  Salerno, L; Pittalà, V; Romeo, G; Modica, MN; Siracusa, MA; Di Giacomo, C; Acquaviva, R; Barbagallo, I; Tibullo, D; Sorrenti, V Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties. Bioorg Med Chem21:5145-53 (2013) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Heme oxygenase 2 |
|---|
| Name: | Heme oxygenase 2 |
|---|
| Synonyms: | HMOX2_RAT | Heme Oxygenase 2 (HO-2) | Heme oxygenase 2 | Hmox2 |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 35754.99 |
|---|
| Organism: | Rattus norvegicus (rat) |
|---|
| Description: | HO-2 obtained from rat brain was used in enzyme assays. |
|---|
| Residue: | 315 |
|---|
| Sequence: | MSSEVETSEGVDESENNSTAPEKENHTKMADLSELLKEGTKEAHDRAENTQFVKDFLKGN
IKKELFKLATTALYFTYSALEEEMDRNKDHPAFAPLYFPTELHRKEALIKDMEYFFGENW
EEQVKCSEAAQKYVDRIHYVGQNEPELLVAHAYTRYMGDLSGGQVLKKVAQRALKLPSTG
EGTQFYLFEHVDNAQQFKQFYRARMNALDLSMKTKERIVEEANKAFEYNMQIFSELDQAG
SMLTKETLEDGLPVHDGKGDVRKCPFYAAQPDKGTLGGSNCPFRTAMAVLRKPSLQLILA
ASVALVAGLLAWYYM
|
|
|
|---|
| BDBM50044424 |
|---|
| n/a |
|---|
| Name | BDBM50044424 |
|---|
| Synonyms: | 4-(((2S,4S)-2-((1H-imidazol-1-yl)methyl)-2-(4-chlorophenethyl)-1,3-dioxolan-4-yl)methylthio)benzenamine | 4-{(2S,4S)-2-[2-(4-Chloro-phenyl)-ethyl]-2-imidazol-1-ylmethyl-[1,3]dioxolan-4-ylmethylsulfanyl}-phenylamine | 4-{2-[2-(4-Chloro-phenyl)-ethyl]-2-imidazol-1-ylmethyl-[1,3]dioxolan-4-ylmethylsulfanyl}-phenylamine | Azalanstat dihydrochloride | CHEMBL70611 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C22H24ClN3O2S |
|---|
| Mol. Mass. | 429.963 |
|---|
| SMILES | Nc1ccc(SC[C@@H]2CO[C@](CCc3ccc(Cl)cc3)(Cn3ccnc3)O2)cc1 |
|---|
| Structure | 
|
|---|
Search and Browse
